Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    - Removed the MedlinePlus Genetics topic: Melanoma. No other content changes detected; overall impact is minor.
    Difference
    0.2%
    Check dated 2025-10-13T11:52:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T06:58:55.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:38:46.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic on Melanoma to the page.
    Difference
    0.2%
    Check dated 2025-09-22T00:20:27.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:36:56.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page has been updated to version 3.0.1, and the section on Melanoma related to MedlinePlus Genetics has been removed.
    Difference
    0.3%
    Check dated 2025-09-07T17:42:56.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.